Table 1.
Overview of different methods that can be applied in zebrafish models for ectopic mineralization.
| Methods | Application | Stages of application in MO approach |
|---|---|---|
| MO injection | To evaluate the gene function by injecting synthetic anti-sense nucleotide oligomers | 1–4 Cell stage embryos |
| Light microscopic observation | Phenotypic screening after injection (see Table 2). | Post-injection to morphant death |
| RNA rescue experiment | Validation of gene specificity by co-injection of MO and mRNA (encoding protein from the targeted locus of other species | 1–4 Cell stages of embryos |
| Western blotting | Validation of the efficiency of TB MOs | After phenotypic confirmation, 1–4 dpf, until when effect of MO can be observed |
| PCR | Expression profiling of targeted gene | From 0- different time points |
| Validation of the efficiency of SJ MOs | After phenotypic confirmation, 1–4 dpf, until when effect of MO can be observed | |
| Quantitative real-time PCR | Expression profiling of targeted gene | From 0- different time points |
| Validation of the efficiency of SJ MOs | After phenotypic confirmation, 1–4 dpf, until when effect of MO can be observed | |
| Calcein staining | Fluorescent chromophores specifically bind to the calcified skeleton of live ZF embryos | 5 dpf to morphant death |
| Alizarin red S | To identify calcium in tissue sections or whole mount embryos | 4 dpf to morphant death |
| Alcian blue-Alizarin red double staining | Alcian blue stains cartilage blue and is used as a counterstaining to AR-S to distinguish cartilage and bone | 4 dpf to morphant death |
| Alizarin red stains as red in calcified matrix (calcified cartilage, bone) | ||
| IHC | To detect presence and localization of (mineralization-related) protein in tissue sections or whole mount embryos | 0 hpf to morphant death |
| μCT imaging | Useful for skeletal analysis, used to understand developmental processes of three-dimensional embryos, embryo phenotyping, and quantitative modeling of development | 5 dpf |
| ISH | To assess gene expression profiling in wild-type embryo and differential gene expression in morphant | 0–4 dpf of embryos, as until 4 dpf effect of MO can be observed |
| MS | To analyze differential protein expression by measuring the mass-to-charge ratio | 0–4 dpf, until MO effect can be observed |
| 2D gel electrophoresis | To assess differential protein expression, where proteins are separated in the gel according to their isoelectric point | 0–4 dpf, until MO effect can be observed |
| Microarray | Used to identify genome-wide expression of genes. In morphant differential expression of different gene can be identified | 0–4 dpf, until MO effect can be observed |
| Transcriptome analysis | More sensitive compared to microarray, used to identify differential expression of transcripts. By this method closely homologous genes can be distinguished, alternatively spliced transcripts and non-coding RNAs can be characterized, and rare transcripts which are undetectable in microarray analysis can be detected | 0–4 dpf, until MO effect can be observed |
| TUNEL staining | To assess in situ cell death in the whole mount embryo. TUNEL labels degraded DNA products enzymatically or by a fluorescent probe and stains apoptotic bodies | 30 hpf–4 dpf, until MO effect can be observed |
| CMH2DCF staining | Used to determine oxidative stress or level of ROS in live embryos | 0–4 dpf, until MO effect can be observed |
| MitoTracker Red CM-H2XRos | Used to determine mitochondrial membrane potentiality in live embryo | 0–4 dpf, until MO effect can be observed |
| Chemical screening | Used to identify small chemicals which can rescue the morphant phenotype and can be predicted as a potential drug | 0–4 dpf, until MO effect can be observed |
MO, morpholino; PCR, polymer chain reaction; IHC, immunohistochemistry; ISH, in situ hybridization; MS, mass spectrophotometry; 2D, 2 dimensional.